Status:
COMPLETED
A Study to Evaluate the Impact on Skin (Injection Site) Reactions of Using Alcohol Wipes Prior to Daily Injections of Copaxone®.
Lead Sponsor:
Teva Neuroscience, Inc.
Conditions:
Multiple Sclerosis
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
This study is designed to compare injection site reactions with or without the use of alcohol wipes prior to performing the patients' daily Copaxone® injection.
Eligibility Criteria
Inclusion
- Male or Female
- 18 years of age or older
- Diagnosis of RRMS
- Beginning or recently (within 3 months) began self-injecting Copaxone® subcutaneously
Exclusion
- Unable to perform subcutaneous self-injection
- Pregnant, or trying to become pregnant, or breast feeding during the study
Key Trial Info
Start Date :
August 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2006
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00220922
Start Date
August 1 2004
End Date
February 1 2006
Last Update
April 8 2011
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.